Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 8, 2008, Pages 733-743

  Bhandari, Sunil ^a,b   Watson, Neil ^c   Long, Ervine ^b   Sharpe, Steve ^b   Zhong, Wenwen ^c   Xu, Shang Zhong ^c   Atkin, Stephen L ^c  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Human kidney; IgA nephropathy; Mesangial cells; Podocytes; Somatostatin; Somatostatin receptors; Tubule

Indexed keywords

G PROTEIN COUPLED RECEPTOR; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; GLOMERULUS; HENLE LOOP; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; MESANGIUM CELL; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOMATOSTATIN;

EID: 47249095867     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.950998     Document Type: Article

References (58)

1. Adams RL, Adams IP, Lindow SW, Atkin SL (2004) Inhibition of endothelial proliferation by the somatostatin analogue SOM230. Clin Endocrinol (Oxf) 61:431-436
2. Adams RL, Adams IP, Lindow SW, Zhong W, Atkin SL (2005) Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium. Br J Cancer 92:1493-1498
3. Balster DA, O'Dorisio MS, Summers MA, Turman MA (2001) Segmental expression of somatostatin receptor subtypes sst(1) and sst(2) in tubules and glomeruli of human kidney. Am J Physiol Renal Physiol 280:F457-465
4. Bates CM, Kegg H, Grady S (2004a) Expression of somatostatin in the adult and developing mouse kidney. Kidney Int 66:1785-1793
5. Bates CM, Kegg H, Grady S (2004b) Expression of somatostatin receptors 1 and 2 in the adult mouse kidney. Regul Pept 119:11-20
6. Bates CM, Kegg H, Petrevski C, Grady S (2003) Expression of somatostatin receptors 3, 4, and 5 in mouse kidney proximal tubules. Kidney Int 63:53-63
7. Benali N, Ferjoux G, Puente E, Buscail L, Susini C (2000) Somatostatin receptors. Digestion 62(suppl 1):27-32
8. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79
9. Bruno JF, Xu Y, Song J, Berelowitz M (1993) Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133:2561-2567
10. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lubbert H (1994) Molecular pharmacology of somatostatin-receptor subtypes. Ann NY Acad Sci 733:138-146
11. Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, et al. (2006) Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. J Nucl Med 47:502-511
12. Danesi R, Agen C, Benelli U, Paolo AD, Nardini D, Bocci G, Basolo F, et al. (1997) Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin Cancer Res 3:265-272
13. Dasgupta P (2004) Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis. Pharmacol Ther 102:61-85
14. Druckenthaner M, Schwarzer C, Ensinger C, Gabriel M, Prommegger R, Riccabona G, Decristoforo C (2007) Evidence for somatostatin receptor 2 in thyroid tissue. Regul Pept 138:32-39
15. Garcia-Escribano C, Diez-Marques ML, Gonzalez-Rubio M, Rodriguez-Puyol M, Rodriguez-Puyol D (1993) Somatostatin antagonizes angiotensin II effects on mesangial cell contraction and glomerular filtration. Kidney Int 43:324-333
16. Garcia-Escribano C, Diez-Marques ML, Medina-Alonso J, Rodriguez-Puyol M, Rodriguez-Puyol D (1994) Somatostatin activates particulate guanylate cyclase in cultured rat mesangial cells. Kidney Int 46:1611-1615
17. Grantham JJ (2006) Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease? Nat Clin Pract Nephrol 2:66-67
18. Green VL, Richmond I, Maguiness S, Robinson J, Helboe L, Adams IP, Drummond NS, et al. (2002) Somatostatin receptor 2 expression in the human endometrium through the menstrual cycle. Clin Endocrinol (Oxf) 56:609-614
19. Hall GH, Turnbull LW, Richmond I, Helboe L, Atkin SL (2002) Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours. Br J Cancer 87:86-90
20. Hatzoglou A, Bakogeorgou E, Papakonstanti E, Stournaras C, Emmanouel DS, Castanas E (1996) Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. J Cell Biochem 63:410-421
21. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, et al. (1991) Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858
22. Jones CR, Millar JA, Lawrie C, Sumner DJ, Reid JL (1984) Specific inhibition of aldosterone responses to endogenous and exogenous angiotensin II by somatostatin. Clin Endocrinol (Oxf) 21:279-284
23. Kimura N, Schindler M, Kasai N, Kimura I (2001) Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues. Endocr J 48:95-102
24. Krantic S (2000) Peptides as regulators of the immune system: emphasis on somatostatin. Peptides 21:1941-1964
25. Kreienkamp HJ, Roth A, Richter D (1998) Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331). DNA Cell Biol 17:869-878
26. Kurokawa K, Aponte GW, Fujibayashi S, Yamada T (1983) Somatostatin-like immunoreactivity in the glomerulus of rat kidney. Kidney Int 24:754-757
27. Mazzocchi G, Malendowicz LK, Meneghelli V, Nussdorfer GG (1992) Evidence that endogenous somatostatin (SRIF) exerts a tonic inhibitory effect on the rat renin-angiotensin-aldosterone system. In Vivo 6:9-12
28. McCaffrey JA, Reuter VV, Herr HW, Macapinlac HA, Russo P, Motzer RJ (2000) Carcinoid tumor of the kidney. The use of somatostatin receptor scintigraphy in diagnosis and management. Urol Oncol 5:108-111
29. Melis M, Krenning EP, Bernard BF, Barone R, Visser TJ, de Jong M (2005) Localisation and mechanism of renal retention of radiolabelled somatostatin analogues. Eur J Nucl Med Mol Imaging 32:1136-1143
30. Moller LN, Stidsen CE, Hartmann B, Holst JJ (2003) Somatostatin receptors. Biochim Biophys Acta 1616:1-84
31. Notas G, Kolios G, Mastrodimou N, Kampa M, Vasilaki A, Xidakis C, Castanas E, et al. (2004) Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors. J Hepatol 40:792-798
32. Pinter E, Helyes Z, Szolcsanyi J (2006) Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112:440-456
33. Pusztaszeri MP, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385-395
34. Ray C, Carney S, Morgan T, Gillies A (1993) Somatostatin as a modulator of distal nephron water permeability. Clin Sci (Lond) 84:455-460
35. Reubi JC, Horisberger U, Studer UE, Waser B, Laissue JA (1993) Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta. J Clin Endocrinol Metab 77:1323-1328
36. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schule R (1993) Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci USA 90:4196-4200
37. Rolleman EJ, Krenning EP, Bernard BF, de Visser M, Bijster M, Visser TJ, Vermeij M, et al. (2007) Long-term toxicity of [(177) Lu-DOTA (0),Tyr (3)]octreotide in rats. Eur J Nucl Med Mol Imaging 34:219-227
38. Roosterman D, Kreuzer OJ, Brune N, Cottrell GS, Bunnett NW, Meyerhof W, Steinhoff M (2007) Agonist-induced endocytosis of rat somatostatin receptor 1. Endocrinology 148:1050-1058
39. Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Antiga L, Ene-Iordache B, Remuzzi G, et al. (2005) Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 68:206-216
40. Schmidt A, Pleiner J, Schaller G, Roden M, Dallinger S, Mayer G, Schmetterer L, et al. (2002) Renal hemodynamic effects of somatostatin are not related to inhibition of endogenous insulin release. Kidney Int 61:1788-1793
41. Schonbrunn A, Tashjian H Jr (1978) Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem 253:6473-6483
42. Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R, Hollt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865-1874
43. Schulz S, Schmitt J, Wiborny D, Schmidt H, Olbricht S, Weise W, Roessner A, et al. (1998a) Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Cancer Res 4:2047-2052
44. Schulz S, Schreff M, Schmidt H, Handel M, Przewlocki R, Hollt V (1998b) ImmunocytochemicaJ localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia. Eur J Neurosci 10:3700-3708
45. Serri O, Brazeau P, Kachra Z, Posner B (1992) Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action. Endocrinology 130:1816-1821
46. Sharma K, Patel YC, Srikant CB (1996) Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 10:1688-1696
47. Sieber C, Gnadinger M, Del Pozo E, Shaw S, Weidmann P (1988) Effect of a new somatostatin analogue SMS 201-995 (Sandostatin) on the renin-aldosterone axis. Clin Endocrinol (Oxf) 28:25-32
48. Stafford ND, Condon LT, Rogers MJ, Helboe L, Crooks DA, Atkin SL (2004) The immunohistochemical localisation of somatostatin receptors 1,2,3, and 5 in acoustic neuromas. J Clin Pathol 57:168-171
49. Stafford ND, Condon LT, Rogers MJ, MacDonald AW, Atkin SL (2003) The expression of somatostatin receptors 1 and 2 in benign, pre-malignant and malignant laryngeal lesions. Clin Otolaryngol Allied Sci 28:314-319
50. Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, Sasano H (2005) Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr J 52:605-611
51. Turman MA, Apple CA (1998) Human proximal tubular epithelial cells express somatostatin: regulation by growth factors and cAMP. Am J Physiol 274:F1095-1101
52. Turman MA, O'Dorisio MS, O'Dorisio TM, Apple CA, Albers AR (1997) Somatostatin expression in human renal cortex and mesangial cells. Regul Pept 68:15-21
53. Uemasu J, Godai K, Tokumoto A, Kawasaki H (1992) Reduced glomerular hypertrophy by somatostatin analog, SMS 201-995, in the subtotal nephrectomized rats fed high-protein meals. J Pharmacol Exp Ther 260:505-508
54. Uemasu J, Tokumoto A, Godai K, Kawasaki H, Hirayama C (1990) Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats. Exp Clin Endocrinol 96:97-104
55. Vegt E, Wetzels JF, Russel FG, Masereeuw R, Boerman OC, van Eerd JE, Corstens FH, et al. (2006) Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin. J Nucl Med 47:432-436
56. Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B, Buscail L, et al. (2005) Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol 152:757-767
57. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999-1017
58. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 89:251-255